Sign in

You're signed outSign in or to get full access.

James Beers

Managing Director and Senior Equity Research Analyst at William Blair Investment Management, LLC

James Beers is a Managing Director and Senior Equity Research Analyst at William Blair, specializing in coverage of the food and beverage and restaurant industries. He has provided analysis on notable companies including Starbucks and Kroger, offering in-depth research on strategic developments and industry trends with a proven track record of driving actionable investment insights for institutional clients. Having joined William Blair after building experience in equity research, Beers has established himself as a top analyst in consumer sectors, consistently delivering thorough sector coverage and recognized research contributions. He maintains professional credentials including FINRA registration and relevant securities licenses, validating his expertise and regulatory compliance within the investment research field.

James Beers's questions to Neuronetics (STIM) leadership

Question · Q3 2024

James Beers of William Blair sought to clarify if the guidance reduction was primarily from treatment sessions and asked for an update on adolescent adoption and the international business. He also questioned why the expanded Better Me Provider (BMP) program wasn't offsetting weakness and asked to confirm the cash flow breakeven timeline.

Answer

CFO Stephen Furlong confirmed the Q4 weakness is mostly related to treatment sessions. CEO Keith Sullivan added that adolescent adoption remains a strong opportunity, particularly within the Greenbrook network post-acquisition. He stated the international focus is on sustaining the business while prioritizing the U.S. market. Furlong clarified that the correct timeline for achieving cash flow breakeven is the third quarter of 2025, not the second.

Ask follow-up questions

Fintool

Fintool can predict Neuronetics logo STIM's earnings beat/miss a week before the call

James Beers's questions to CUTR leadership

Question · Q1 2024

Asked about the current macroeconomic and financing environment for capital equipment in aesthetics, and how to model capital revenue for the upcoming quarters.

Answer

The executive confirmed a challenging macro environment with difficult financing and sluggish practice volumes, particularly in the body contouring segment, which was anticipated in their guidance. For modeling, they expect a sequential increase in capital revenue from Q1 to Q2, with the second half of the year being stronger than the first, supported by the Xeo Plus launch and a strengthened sales team.

Ask follow-up questions

Fintool

Fintool can predict CUTR logo CUTR's earnings beat/miss a week before the call